| __timestamp | Viridian Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7751000 | 1643000000 |
| Thursday, January 1, 2015 | 10251000 | 1532000000 |
| Friday, January 1, 2016 | 9575000 | 1364000000 |
| Sunday, January 1, 2017 | 10912000 | 1334000000 |
| Monday, January 1, 2018 | 11049000 | 1484000000 |
| Tuesday, January 1, 2019 | 11646000 | 1638000000 |
| Wednesday, January 1, 2020 | 13265000 | 1726000000 |
| Friday, January 1, 2021 | 25805000 | 2001000000 |
| Saturday, January 1, 2022 | 35182000 | 2009000000 |
| Sunday, January 1, 2023 | 94999000 | 2151000000 |
| Monday, January 1, 2024 | 2318000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of the pharmaceutical industry, understanding operational costs is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Zoetis Inc. and Viridian Therapeutics, Inc. over the past decade. From 2014 to 2023, Zoetis Inc. consistently demonstrated robust financial management, with SG&A expenses averaging around $1.7 billion annually. In contrast, Viridian Therapeutics, Inc. showed a more volatile pattern, with expenses peaking at nearly $95 million in 2023, a staggering 1,100% increase from 2014. This disparity highlights Zoetis's stable growth and Viridian's aggressive expansion strategy. As the industry continues to grow, these insights provide a window into the strategic financial decisions shaping the future of these companies.
AbbVie Inc. vs Zoetis Inc.: SG&A Expense Trends
Gilead Sciences, Inc. and Zoetis Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Zoetis Inc. vs Teva Pharmaceutical Industries Limited Trends and Insights
SG&A Efficiency Analysis: Comparing Zoetis Inc. and Neurocrine Biosciences, Inc.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Mesoblast Limited
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Ascendis Pharma A/S vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Pharming Group N.V. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Galapagos NV vs Viridian Therapeutics, Inc.